274 related articles for article (PubMed ID: 27769809)
1. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
Mahadevan U; McConnell RA; Chambers CD
Gastroenterology; 2017 Feb; 152(2):451-462.e2. PubMed ID: 27769809
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications.
McConnell RA; Mahadevan U
Gastroenterol Clin North Am; 2016 Jun; 45(2):285-301. PubMed ID: 27261899
[TBL] [Abstract][Full Text] [Related]
3. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding.
Gisbert JP
Inflamm Bowel Dis; 2010 May; 16(5):881-95. PubMed ID: 19885906
[TBL] [Abstract][Full Text] [Related]
4. The use of biologic therapy in pregnancy: a gastroenterologist's perspective.
Hassid B; Mahadevan U
Curr Opin Rheumatol; 2014 May; 26(3):347-53. PubMed ID: 24625373
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease: management issues during pregnancy.
Ferrero S; Ragni N
Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease.
Saha S; Wald A
Expert Opin Drug Saf; 2012 Nov; 11(6):947-57. PubMed ID: 22954378
[TBL] [Abstract][Full Text] [Related]
7. Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
McConnell RA; Mahadevan U
Inflamm Bowel Dis; 2016 Jan; 22(1):213-23. PubMed ID: 26444103
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
[TBL] [Abstract][Full Text] [Related]
9. Biologics and pregnancy: a clinician's guide to the management of IBD in pregnant women.
Guerrero Vinsard D; Kane SV
Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):633-641. PubMed ID: 33440996
[No Abstract] [Full Text] [Related]
10. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
Ban L; Tata LJ; Fiaschi L; Card T
Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
[TBL] [Abstract][Full Text] [Related]
11. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.
Connell W; Miller A
Drug Saf; 1999 Oct; 21(4):311-23. PubMed ID: 10514022
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease and pregnancy: an update.
Kwan LY; Mahadevan U
Expert Rev Clin Immunol; 2010 Jul; 6(4):643-57. PubMed ID: 20594137
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
Moffatt DC; Bernstein CN
Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
[TBL] [Abstract][Full Text] [Related]
14. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
15. [Inflammatory bowel disease and pregnancy].
Couve S; Seksik P; Elefant E; Jian R; Marteau P
Gastroenterol Clin Biol; 2003 Jun; 27(6-7):618-26. PubMed ID: 12910228
[No Abstract] [Full Text] [Related]
16. Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan.
Naganuma M; Kunisaki R; Yoshimura N; Nagahori M; Yamamoto H; Kimura H; Sako M; Kawaguchi T; Takazoe M; Yamamoto S; Matsui T; Hibi T; Watanabe M
J Crohns Colitis; 2011 Aug; 5(4):317-23. PubMed ID: 21683301
[TBL] [Abstract][Full Text] [Related]
17. [Inflammatory bowel diseases: conservative therapy].
Bansky G
Ther Umsch; 1991 Jul; 48(7):464-70. PubMed ID: 1926006
[TBL] [Abstract][Full Text] [Related]
18. The use of biologic agents in pregnancy and breastfeeding.
Horst S; Kane S
Gastroenterol Clin North Am; 2014 Sep; 43(3):495-508. PubMed ID: 25110255
[TBL] [Abstract][Full Text] [Related]
19. Update on pregnancy and breastfeeding in the era of biologics.
Yarur A; Kane SV
Dig Liver Dis; 2013 Oct; 45(10):787-94. PubMed ID: 23474350
[TBL] [Abstract][Full Text] [Related]
20. IBD medications during pregnancy and lactation.
Nielsen OH; Maxwell C; Hendel J
Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):116-27. PubMed ID: 23897285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
